Health Care: Drugs

Sinovac Biotech Ltd (SVA: NASDAQ)

$5.57 -0.01 | -0.18%
08/20/14 - 10:15 AM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 72.52M 49.22M 56.84M 33.40M
Cost of Sales 14.43M 15.97M 17.36M 13.78M
Gross Operating Profit 58.10M 33.24M 39.48M 19.62M
Selling, General, and Administrative Expenses 34.03M 30.81M 22.21M 20.68M
Research & Development 8.38M 17.04M 9.01M 8.64M
Operating Income before D & A (EBITDA) 15.68M -14.61M 8.27M -9.69M
Depreciation & Amortization 6.84M 4.72M 5.20M 4.35M
Interest Income 2.17M 2.37M 1.40M 1.13M
Other Income - Net 263.00K -851.57K 588.57K -1.14M
Special Income / Charges -88.00K -1.82M 0.00 1.92M
Total Income Before Interest Expenses (EBIT) 11.18M -19.63M 5.05M -12.13M
Interest Expense 3.03M 0.00 384.56K 1.18M
Pre-Tax Income 8.14M -19.63M 4.67M -13.31M
Income Taxes -2.22M -883.90K 5.07M -703.88K
Minority Interest 2.93M -3.90M 445.00K -4.09M
Net Income From Continuing Operations 10.37M -18.75M -399.69K -12.60M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 10.37M -18.75M -399.69K -12.60M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 7.44M -14.85M -844.70K -8.51M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
10.46M -16.93M -399.69K -14.53M
Preferred Dividends
Net Income Available To Common 10.37M -18.75M -399.69K -12.60M
Basic EPS from Continuing Ops. 0.13 -0.27 -0.02 -0.16
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 0.13 -0.27 -0.02 -0.16
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 0.13 -0.27 -0.02 -0.16
Basic Normalized Net Income/Share 0.14 -0.24 -0.02 -0.18
EPS fr Continuing Ops. 0.13 -0.27 -0.02 -0.16
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 0.13 -0.27 -0.02 -0.16
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 0.13 -0.27 -0.02 -0.16
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0.13 -0.24 -0.02 -0.18
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with SVA

Latest SVA Headlines from TheStreet

More Financial News for SVA

Press Releases for SVA

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter